L&T Finance to raise up to Rs 100 cr by issuing securities
L&T Finance Holdings Wednesday said it will raise up to Rs 100 crore by issuing compulsorily redeemable securities on private placement basis.
L&T Finance Holdings Wednesday said it will raise up to Rs 100 crore by issuing compulsorily redeemable securities on private placement basis. The company's committee of directors has approved an offer for issuing up to 1 crore cumulative compulsorily redeemable non-convertible preference shares (CRPS) to raise up to Rs 100 crore, it said in a regulatory filing. L&T Finance said the CRPS will carry dividend of 7.95 per cent per annum payable annually. The tenure of the securities is 3 years and 6 months.
"In the event of a default in the payment of the dividend/principal on the due date, an additional dividend amount will be payable at the rate of 2 per cent per annum over the dividend rate by the company for the defaulting period," L&T Finance said. Stock of the company closed 1.64 per cent up at Rs 133 on BSE.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
SIP in Stocks For New Year 2025: Market guru Anil Singhvi recommends 1 largecap, 2 midcap scrips to buy in dips; note down targets
PPF vs SIP: Rs 12,000 monthly investment for 30 years; see which can create higher retirement corpus
Top 7 Index Mutual Funds With Best SIP Returns in 10 Years: Rs 11,111 monthly SIP investment in No. 1 fund is now worth Rs 33,18,831; know how others have fared
Largecap PSU Stock for 65% Gain in New Year: Anil Singhvi picks PSU bank for long term; know reasons and target prices
Largecap, Midcap Stocks To Buy: Analysts recommend buying L&T, Tata Motors, 3 other stocks for 2 weeks; check targets
Power of Rs 15,000 SIP: How long it will take to achieve Rs 7 crore corpus? See calculations to know
SIP Stock Pick For New Year 2025: Anil Singhvi recommends buying this largecap pharma stock on 10% dip
06:04 PM IST